Eugene Tu Email & Phone Number

At OHSU Knight Cancer's CEDAR, my leadership is defined by pioneering liquid biopsy assays and progressive technology for multi-cancer early detection. The launch of an internal accelerator marks our commitment to transforming novel research into entrepreneurial success, fostering a culture of commercial viability and innovation. Biotechnology Innovator with a track record of creating valueNanogen, scientific co-founder, IPOGenoptix, key employee, acquired by NovartisVeriskin, co-founder, entering clinical trialsOmniome, co-founder, acquired by PacBioCurrent Passion Project:* Combining next-gen proteomics & advanced ex-vivo models to discover new drug targets and biomarkers for blood cancers (Acute Myeloid Leukemia, Multiple Myeloma, ...)* Kickstarting the PDX bioeconomy via a top-down approachPast Successes:* Developed new NGS sequencing chemistry at Omniome, built and managed team of 50+, raised $65M financing, acquired by Pacific Biosciences.* Managed a multi-site pilot study for a novel skin cancer detection device at Veriskin, results bested all existing competitors.* Developed a cell mimic technology for detecting RNA viruses as part of a $4M HSARPA grant. Demonstrated feasibility in influenza for air monitoring. Could be modified for SARS-CoV-2 virus* Co-invented Nanogen’s focal DNA chip technology, >$2 billion market cap on Nasdaq.* Experienced writer and manager of grants, >$11M in funding from NIH, DOJ, NSF, DOD, & DHS.* Developed a self-contained benchtop cell sorter at Genoptix, spun-out as Celula, Inc., technology licensed to a NYSE listed life sciences company.* 100+ issued US & International patents in 39 families. Intimately involved in IP mining and strategy.Skills:* Scientific expertise in molecular biology, chemistry, microfluidics, nanotechnology, and photonics.* Proven track record of success in developing and commercializing innovative technologies.* Strong leadership and management skills.* Extensive experience in grant writing and fundraising.* Deep understanding of FDA regulations.* Passionate about using technology to solve real-world problems.